Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

Washington,
D.C. 20549

FORM
SD

Specialized
Disclosure Report

Stereotaxis,
Inc.

(Exact
name of registrant as specified in its charter)

Kimberly
R. Peery 314-678-6100

(Name
and telephone number, including area code, of the person to contact in connection with this report.)

Check
the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information
in this form applies:

☒
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2021.

Section
1 – Conflict Minerals Disclosure

Item
1.01 Conflict Minerals Disclosure and Report

This
Specialized Disclosure Report on Form SD (“Form SD”) of Stereotaxis, Inc. (“Stereotaxis”, the “Company”
or “we”) for the reporting period from January 1 to December 31, 2021, is filed pursuant to Rule 13p-1 under the Securities
Exchange Act of 1934 (the “Rule”). Capitalized terms not otherwise defined herein are defined in the Rule.

Stereotaxis
evaluated its products and determined that our products contain “necessary conflict minerals.” This means that Conflict Minerals
as defined in the Rule are present in products we manufacture or contract to manufacture and are used to achieve the required function,
use or purpose of those products. Our determination and related disclosures relating to such necessary conflict minerals are included
in Stereotaxis’ Conflict Minerals Report and are incorporated by reference herein.

Item
1.02 Exhibit

The
Company has filed a Conflict Minerals Report as Exhibit 1.01 to this Form SD. Stereotaxis’ Conflict Minerals Report is available
at http://www.stereotaxis.com/legal/. The website and the information accessible through it are not incorporated into this Form
SD.

Section
2 – Exhibits

Item
2.01 Exhibits

Exhibit
1.01 Stereotaxis, Inc. Conflict Minerals Report for the reporting period January 1 to December 31, 2021

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the duly authorized undersigned.

Exhibit
1.01

Stereotaxis,
Inc.

Conflict
Minerals Report

For
The Year Ended December 31, 2021

Introduction

This
Conflict Minerals Report for Stereotaxis, Inc. (“Stereotaxis”, “we,” “us,” and “our”)
is for the period from January 1 to December 31, 2021 and is presented to comply with Rule 13p-1 under the Securities Exchange Act of
1934 (“Rule”). Terms used in this report are defined in the Rule and Form SD. Refer to those sources and to SEC Release No.
34-67716 issued by the Securities and Exchange Commission on August 22, 2012 for such definitions.

Stereotaxis
designs, manufactures and markets an advanced robotic magnetic navigation system for use in a hospital’s interventional surgical
suite, or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias by enabling enhanced safety,
efficiency, and efficacy for catheter-based, or interventional, procedures. Our primary products include the Genesis RMN System, the
Odyssey Solution, and related devices. We also offer to our customers the Stereotaxis Imaging Model S x-ray System.

The
Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery
of catheters through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic
fields that govern the motion of the working tip of the catheter, resulting in improved navigation, efficient procedures, and reduced
x-ray exposure.

In
addition to the robotic magnetic navigation systems and their components, Stereotaxis also has developed the Odyssey Solution, which
consolidates lab information enabling physicians to focus on the patient for optimal procedure efficiency. The system also features a
remote viewing and recording capability called Odyssey Cinema, which is an innovative solution that delivers synchronized content for
optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store
and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local
area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and
training.

This
Report describes the process and results of Stereotaxis’ Conflict Minerals program. Stereotaxis performed a Reasonable Country
of Origin Inquiry (RCOI) to determine the source of necessary conflict minerals in our products, and in accordance with the Rule then
undertook due diligence measures on the source and chain of custody of those necessary conflict minerals. The purpose of this due diligence
was to determine if any of the necessary conflict minerals originated from the Democratic Republic of the Congo (“DRC”) or
an adjoining country (collectively defined as the “Covered Countries”) and may not have come from recycled or scrap sources,
to determine whether such products are “DRC conflict free.”

Consistent
with the provisions of the Rule, this Conflict Minerals Report has not been audited by an independent private sector auditor.

Design
of Conflict Minerals Program and Due Diligence Process

Stereotaxis
has a Conflict Minerals program designed to be in conformance with the Organisation for Economic Co-operation and Development Due Diligence
Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas, 3^rd Edition, including the
Supplement on Tin, Tantalum and Tungsten, and the Supplement on Gold (collectively, the “OECD Guidance”). In the context
of the OECD Guidance Stereotaxis is a “downstream company” in the conflict minerals supply chain. Summarized below are the
five due diligence steps taken which align with the OECD Guidance five-step framework:

2.
Identified and assessed risks in the conflict minerals supply chain:

3.
Designed and implemented a strategy to respond to identified risks:

4.
Carried out independent third-party audit of supply chain due diligence at identified points in the supply chain:

5.
Reported on supply chain due diligence:

The
content of any website referred to in this Report is included for general information only and is not incorporated by reference in this
Report.

Reasonable
Country of Origin Inquiry Results

Following
the Conflict Minerals program described above, Stereotaxis identified 157 suppliers and original equipment manufacturers in our direct
supply chain. We identified 116 of those suppliers as the ones who provide us with components,
materials and assemblies where Conflict Minerals are present and necessary to functionality, or for which we were unsure whether
the materials or components contained Conflict Minerals. We then performed a RCOI with those 116 suppliers and requested each of them
to supply us with a CMRT. 89 of those suppliers provided us with a CMRT.

The
CMRT’s we received contained a large number of smelter or refiner names for the facilities these suppliers and their upstream suppliers
use to process Conflict Minerals, as well as the specific Conflict Mineral(s) used in their products. After correction, review, and removal
of duplicate or alternate names, and elimination of entities we determined were not actually smelters or refiners, and elimination of
entities for which we were unable to determine if they were a relevant smelter or refiner, we identified 333 unique smelters.

Of
the 333 identified smelters or refiners in our supply chain, our analysis leads us to believe that:

In
accordance with the SEC final rules for Conflict Minerals sourced from Covered Countries, because some smelters in our supply chain were
identified to be sourcing from Covered Countries, Stereotaxis is required to exercise, and has exercised, due diligence on the Conflict
Minerals’ source and chain of custody. Additionally, Stereotaxis is required to follow, and has followed, a nationally or internally
recognized due diligence framework (specifically the OECD Guidance) and report the results thereof in a Conflict Minerals report.

Due
Diligence Process Results

Of
the 49 smelters in our supply chain that are known to source Conflict Minerals from the Covered Countries, Stereotaxis’ due diligence
review indicates:

Based
upon responses received from our suppliers as part of RCOI, and our due diligence efforts, we have not been able to confirm that all
smelters reported by our suppliers as being in our supply chain are DRC conflict-free.

Stereotaxis
did not discontinue business with any supplier simply because the supplier sourced conflict minerals from the Covered Countries. We support
conflict-free minerals trade in the DRC region.

Product
Determination

Based
upon responses received from our suppliers as part of RCOI, we have not been able to confirm the identification of all smelters in our
supply chain, nor confirm that all smelters reported by our suppliers as being in our supply chain are DRC conflict-free.

Facility
and Mine Information

The
table below identifies all the smelter or refiner facilities which, to the extent known as a result of our RCOI, processed the necessary
conflict minerals contained in our products. A “Yes” entry in the rightmost column indicates the smelter or refiner has received
a conformant smelter designation from an independent third-party audit program.